Pre-ESMO 2022

The IQVIA Institute for Human Data Science, in collaboration with DIGICORE, the Digital Institute for Cancer Outcomes Research, and the IQVIA Oncology Center of Excellence, will host a pre-ESMO symposium to discuss advances in clinical development in oncology. The event will draw upon a recent report published by the IQVIA Institute – Global Oncology Trends 2022 – and will feature a panel of industry thought leaders in oncology who are focused on the promise, research challenges, and care implementation of precision medicine, a major focus for the European Cancer Mission.

The symposium is a non-commercial event and open to the public. Attendees will include clinicians, patient organization leaders, policymakers, academic researchers, and leaders from pharma, biopharma and other areas of the life sciences.

• If you are attending ESMO, you may register for the live, in-person event.
• If you are unable to attend the live, in-person event, please register for the webinar.

Speakers

Pierfranco Conte,
MD Professor, Department of Surgery, Oncology and Gastroenterology IOV - Instituto Oncologgico Veneto, I.R.C.C.S.

Aslaug Helland,
MD, Ph.D. Head of Research, Division of Cancer Medicine Oslo University Hospital

Ebba Hallersjö Hult
Co-founder and Head Vision Zero Cancer / Test Bed Sweden for Precision Health in Cancer

Jeffrey Keefer,
MD, Ph.D. Head, Hematology and Oncology Center of Excellence IQVIA

Iwona Ługowska,
MD, Ph.D. Head of Early Phase Clinical Trials Unit Maria Sklodowska Curie National Research Institute of Oncology

Piers Mahon,
Ph.D. Senior Principal, European Data and Evidence Networks, IQVIA Commercial Research Manager, DIGICORE

Tony Mok,
MD Professor, Department of Clinical Oncology Chinese University of Hong Kong

Bettina Ryll,
Ph.D. Founder Melanoma Patient Network Europe

Pier Mahon,
Ph.D. Senior Principal, European Data and Evidence Networks, Commercial Research Manager IQVIA, DIGICORE

Moderator:

Murray Aitken,
Executive Director, IQVIA Institute for Human Data Science